Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

The restaurant group announced Tuesday that Jose Alberto Dueñas is stepping down. Chief financial officer Paul Carbone, a ...

Bloks Group Ltd., the popular maker of Ultraman and Transformers figurines, raised HK$1.67 billion ($215 million) in Hong ...

(Reuters) -Oilfield services provider Flowco Holdings on Tuesday said it is seeking a valuation of up to $2 billion in its ...

Spanish travel technology firm HBX Group is considering announcing plans for an initial public offering as early as next week ...

The IPO’s upper price band is at ₹52. The ₹25.12 crore IPO closed on January 3, 2025, oversubscribed 182 times. The company ...

The initial public offering (IPO) of Standard Glass Lining Technology Ltd enters its third and the last day of bidding today, ...

The share allotment of Fabtech Technologies IPO is expected to be finalized soon. Investors can check their allotment status ...

The strong subscription aligns with grey market trends, as Standard Glass Lining's unlisted shares were commanding a premium ...

Leo Dry Fruits shares listed at Rs 68 apiece on the BSE SME, reflecting a premium of Rs 16 or 30.77 per cent over the IPO ...

The ₹1,250 crore issue includes a fresh equity offering of up to ₹210 crore and an offer for sale of up to 1.42 crore shares, ...

Drug developer Maze Therapeutics Inc.'s rollercoaster ride is leading to the Bay Area's first biotech IPO filing of 2025.